1. Home
  2. VEEV vs KVUE Comparison

VEEV vs KVUE Comparison

Compare VEEV & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veeva Systems Inc.

VEEV

Veeva Systems Inc.

HOLD

Current Price

$172.55

Market Cap

27.4B

Sector

Technology

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.71

Market Cap

32.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VEEV
KVUE
Founded
2007
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Specialty Chemicals
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
27.4B
32.9B
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
VEEV
KVUE
Price
$172.55
$17.71
Analyst Decision
Buy
Buy
Analyst Count
25
11
Target Price
$280.42
$19.45
AVG Volume (30 Days)
2.4M
19.7M
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
4.82%
EPS Growth
25.93
40.74
EPS
5.44
0.25
Revenue
$1,104,081,000.00
$15,124,000,000.00
Revenue This Year
$14.42
$4.85
Revenue Next Year
$12.17
$2.63
P/E Ratio
$32.67
$67.48
Revenue Growth
28.05
N/A
52 Week Low
$148.05
$14.02
52 Week High
$310.50
$22.87

Technical Indicators

Market Signals
Indicator
VEEV
KVUE
Relative Strength Index (RSI) 54.99 56.07
Support Level $172.59 $16.89
Resistance Level $184.71 $17.88
Average True Range (ATR) 8.14 0.38
MACD 1.98 -0.01
Stochastic Oscillator 52.14 77.05

Price Performance

Historical Comparison
VEEV
KVUE

About VEEV Veeva Systems Inc.

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Share on Social Networks: